
Cardiovascular Toxicities of Cancer Therapies
Brian Colwell Jensen, MD, will introduce the audience to potential cardiovascular adverse effects of contemporary cancer therapeutics.
Target Audience
These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, registered nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, allied health personnel, and others who are interested in care for patients and survivors in North Carolina.
Learning Objectives
- Recall that cancer therapies can have on-target and off-target effects on the cardiovascular system.
- Explain that trastuzumab is associated with cardiomyopathy.
- Recognize that kinase inhibitors that target the VEGF signaling pathway frequently cause hypertension.
- Discuss how myocarditis is a rare but potentially fatal complication of immune checkpoint inhibitors.
Taking the Course
To continue, click the button Take Course.
If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at [email protected] or (919) 445–1000.
![]() | Cancer Treatment in North Carolina: Research to Practice (formerly Medical and Surgical Oncology) webinars cover the spectrum of anti-cancer therapy, with a focus on recent research developments, both locally and at large, and what’s ready for regular practice. Perspectives from medical oncology, radiation oncology, and surgery will be included. These webinars provide FREE continuing education credit. |
![]() | Brian Colwell Jensen, MD Associate Professor of Medicine |
This Non-Credit Course does not have accreditation. It only offers general participation certificates. |
Available Credit
- 1.00 Participation
You must have an account and be logged in to register for and to access the course.
Requirements for Receiving Free General Participation Certificates
|